Cytovia Therapeutics Email Format

Biotechnology ResearchFlorida, United States2-10 Employees

Cytovia Therapeutics is a biotechnology company developing off-the-shelf immunotherapies that harness natural killer cells to confront cancer. The company combines stem cell–derived NK cell therapies with antibody-based approaches designed to direct NK cells to tumors. Its programs target solid tumors, including hepatocellular carcinoma and glioblastoma, as well as hematologic cancers such as refractory multiple myeloma. The work is intended to improve patient access to NK cell–based treatments.

Headquartered in Aventura, Florida, Cytovia maintains research operations in Natick, Massachusetts, and a GMP manufacturing facility in Puerto Rico, reflecting a distributed footprint. It has scientific collaborations with Cellectis, CytoImmune, the Hebrew University of Jerusalem, INSERM, the New York Stem Cell Foundation, the National Cancer Institute, and UCSF, and recently established CytoLynx Therapeutics to support R&D, manufacturing, and commercialization activities in Greater China and beyond.

Get verified Cytovia Therapeutics emails free

Company overview Employee directory